• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗链球菌内溶素作为一种抗生素替代品。

Endolysins against Streptococci as an antibiotic alternative.

作者信息

Wong Kuan Yee, Megat Mazhar Khair Megat Hamzah, Song Adelene Ai-Lian, Masarudin Mas Jaffri, Chong Chou Min, In Lionel Lian Aun, Teo Michelle Yee Mun

机构信息

Department of Biotechnology, Faculty of Applied Sciences, UCSI University, Kuala Lumpur, Malaysia.

Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

出版信息

Front Microbiol. 2022 Aug 2;13:935145. doi: 10.3389/fmicb.2022.935145. eCollection 2022.

DOI:10.3389/fmicb.2022.935145
PMID:35983327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9378833/
Abstract

Multi-drug resistance has called for a race to uncover alternatives to existing antibiotics. Phage therapy is one of the explored alternatives, including the use of endolysins, which are phage-encoded peptidoglycan hydrolases responsible for bacterial lysis. Endolysins have been extensively researched in different fields, including medicine, food, and agricultural applications. While the target specificity of various endolysins varies greatly between species, this current review focuses specifically on streptococcal endolysins. spp. causes numerous infections, from the common strep throat to much more serious life-threatening infections such as pneumonia and meningitis. It is reported as a major crisis in various industries, causing systemic infections associated with high mortality and morbidity, as well as economic losses, especially in the agricultural industry. This review highlights the types of catalytic and cell wall-binding domains found in streptococcal endolysins and gives a comprehensive account of the lytic ability of both native and engineered streptococcal endolysins studied thus far, as well as its potential application across different industries. Finally, it gives an overview of the advantages and limitations of these enzyme-based antibiotics, which has caused the term enzybiotics to be conferred to it.

摘要

多重耐药性促使人们竞相寻找现有抗生素的替代品。噬菌体疗法是其中一种被探索的替代方法,包括使用内溶素,内溶素是噬菌体编码的肽聚糖水解酶,负责细菌裂解。内溶素已在不同领域进行了广泛研究,包括医学、食品和农业应用。虽然各种内溶素的靶标特异性在不同物种之间差异很大,但本综述特别关注链球菌内溶素。链球菌会引发多种感染,从常见的链球菌性喉炎到更严重的危及生命的感染,如肺炎和脑膜炎。据报道,它在各个行业都是一场重大危机,会导致与高死亡率和高发病率相关的全身感染以及经济损失,尤其是在农业领域。本综述重点介绍了链球菌内溶素中发现的催化结构域和细胞壁结合结构域的类型,并全面阐述了迄今为止所研究的天然和工程化链球菌内溶素的裂解能力,以及其在不同行业的潜在应用。最后,概述了这些基于酶的抗生素的优点和局限性,因此赋予了它“酶抗生素”这一术语。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8831/9378833/f418d185df91/fmicb-13-935145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8831/9378833/d11e9505217b/fmicb-13-935145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8831/9378833/f418d185df91/fmicb-13-935145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8831/9378833/d11e9505217b/fmicb-13-935145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8831/9378833/f418d185df91/fmicb-13-935145-g002.jpg

相似文献

1
Endolysins against Streptococci as an antibiotic alternative.抗链球菌内溶素作为一种抗生素替代品。
Front Microbiol. 2022 Aug 2;13:935145. doi: 10.3389/fmicb.2022.935145. eCollection 2022.
2
Bacteriophage-derived endolysins as innovative antimicrobials against bovine mastitis-causing streptococci and staphylococci: a state-of-the-art review.噬菌体衍生的溶菌素作为抗奶牛乳腺炎链球菌和葡萄球菌的创新型抗菌药物:最新综述。
Acta Vet Scand. 2024 May 20;66(1):20. doi: 10.1186/s13028-024-00740-2.
3
Engineered phage enzymes against drug-resistant pathogens: a review on advances and applications.工程噬菌体酶对抗耐药病原体:进展与应用综述。
Bioprocess Biosyst Eng. 2024 Mar;47(3):301-312. doi: 10.1007/s00449-023-02938-6. Epub 2023 Nov 14.
4
Bacteriophage endolysins as a novel class of antibacterial agents.噬菌体溶菌酶作为一类新型抗菌剂。
Exp Biol Med (Maywood). 2006 Apr;231(4):366-77. doi: 10.1177/153537020623100402.
5
Phage-Encoded Endolysins.噬菌体编码的内溶素
Antibiotics (Basel). 2021 Jan 28;10(2):124. doi: 10.3390/antibiotics10020124.
6
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.溶菌素作为对抗耐药性感染的新兴替代治疗药物。
Int J Antimicrob Agents. 2020 Feb;55(2):105844. doi: 10.1016/j.ijantimicag.2019.11.001. Epub 2019 Nov 9.
7
Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.协同性链球菌噬菌体λSA2和B30溶菌酶可在牛奶及乳腺炎小鼠模型中杀死链球菌。
Appl Microbiol Biotechnol. 2015 Oct;99(20):8475-86. doi: 10.1007/s00253-015-6579-0. Epub 2015 Apr 21.
8
From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.从内溶素到Artilysin®s:基于新型酶的抗耐药菌方法
Biochem Soc Trans. 2016 Feb;44(1):123-8. doi: 10.1042/BST20150192.
9
The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis.噬菌体溶菌酶的多结构域架构能够实现分子内协同作用和细菌裂解的调控。
J Biol Chem. 2021 Jan-Jun;296:100639. doi: 10.1016/j.jbc.2021.100639. Epub 2021 Apr 8.
10
The Advantages and Challenges of Using Endolysins in a Clinical Setting.在临床环境中使用内切溶素的优势和挑战。
Viruses. 2021 Apr 15;13(4):680. doi: 10.3390/v13040680.

引用本文的文献

1
Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and Recent Applications.抗耐药葡萄球菌属的噬菌体衍生内溶素:特性、抗菌活性及近期应用综述
Infect Dis Ther. 2025 Jan;14(1):13-57. doi: 10.1007/s40121-024-01069-z. Epub 2024 Nov 16.
2
Role of hypothetical protein PA1-LRP in antibacterial activity of endolysin from a new phage PA1.假定蛋白PA1-LRP在新型噬菌体PA1的内溶素抗菌活性中的作用
Front Microbiol. 2024 Oct 23;15:1463192. doi: 10.3389/fmicb.2024.1463192. eCollection 2024.
3
Streptococcus pneumoniae epidemiology, pathogenesis and control.

本文引用的文献

1
Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: recent advances and future trends.用于食品中病原菌生物防治的噬菌体和内溶素工程:最新进展与未来趋势
Crit Rev Food Sci Nutr. 2023;63(27):8919-8938. doi: 10.1080/10408398.2022.2059442. Epub 2022 Apr 9.
2
secreting phage lysins as a potential antimicrobial against multi-drug resistant .分泌噬菌体溶素作为一种针对多重耐药菌的潜在抗菌剂。
PeerJ. 2022 Mar 1;10:e12648. doi: 10.7717/peerj.12648. eCollection 2022.
3
Endolysin, a Promising Solution against Antimicrobial Resistance.
肺炎链球菌的流行病学、发病机制与防控
Nat Rev Microbiol. 2025 Apr;23(4):256-271. doi: 10.1038/s41579-024-01116-z. Epub 2024 Nov 6.
4
Identification of cell wall binding domains and repeats in phage endolysins: A molecular and diversity analysis.噬菌体溶菌酶中细胞壁结合结构域和重复序列的鉴定:分子与多样性分析
Biochem Biophys Rep. 2024 Oct 14;40:101844. doi: 10.1016/j.bbrep.2024.101844. eCollection 2024 Dec.
5
Bacteriophage as a potential biotherapeutics to combat present-day crisis of multi-drug resistant pathogens.噬菌体作为应对当今多重耐药病原体危机的一种潜在生物疗法。
Heliyon. 2024 Sep 5;10(18):e37489. doi: 10.1016/j.heliyon.2024.e37489. eCollection 2024 Sep 30.
6
Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.靶向细菌细胞壁的药物:对抗革兰氏阳性病原体的工具。
Molecules. 2024 Aug 27;29(17):4065. doi: 10.3390/molecules29174065.
7
Identification and Characterization of a Novel Prophage Lysin against .鉴定和表征一种新型针对. 的噬菌体溶素
Molecules. 2024 Jul 20;29(14):3411. doi: 10.3390/molecules29143411.
8
LysSYL: a broad-spectrum phage endolysin targeting Staphylococcus species and eradicating S. aureus biofilms.LysSYL:一种广谱噬菌体溶菌素,靶向葡萄球菌属并根除金黄色葡萄球菌生物膜。
Microb Cell Fact. 2024 Mar 25;23(1):89. doi: 10.1186/s12934-024-02359-4.
9
Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications.三聚体孔蛋白、内溶素和间隔子的分子机制:参与噬菌体诱导细胞裂解的关键因子及其治疗应用。
Protein Pept Lett. 2024;31(2):85-96. doi: 10.2174/0109298665181166231212051621.
10
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae.内溶素 EN572-5 可作为治疗无乳链球菌引起的尿路感染的一种替代方法。
Appl Microbiol Biotechnol. 2024 Dec;108(1):79. doi: 10.1007/s00253-023-12949-8. Epub 2024 Jan 8.
内溶素,一种对抗抗生素耐药性的有前景的解决方案。
Antibiotics (Basel). 2021 Oct 20;10(11):1277. doi: 10.3390/antibiotics10111277.
4
Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria.基于内溶素的革兰氏阴性菌治疗现状
Antibiotics (Basel). 2021 Sep 22;10(10):1143. doi: 10.3390/antibiotics10101143.
5
The effectiveness of extended binding affinity of prophage lysin PlyARI against Streptococcus suis infection.噬菌体溶素 PlyARI 延长的结合亲和力对猪链球菌感染的有效性。
Arch Microbiol. 2021 Oct;203(8):5163-5172. doi: 10.1007/s00203-021-02438-9. Epub 2021 Aug 2.
6
Phage and phage lysins: New era of bio-preservatives and food safety agents.噬菌体和噬菌体裂解酶:生物防腐剂和食品安全剂的新时代。
J Food Sci. 2021 Aug;86(8):3349-3373. doi: 10.1111/1750-3841.15843. Epub 2021 Jul 23.
7
Bacteriophage and Endolysin Encapsulation Systems: A Promising Strategy to Improve Therapeutic Outcomes.噬菌体和内溶素封装系统:改善治疗效果的一种有前景的策略。
Front Pharmacol. 2021 May 7;12:675440. doi: 10.3389/fphar.2021.675440. eCollection 2021.
8
The Advantages and Challenges of Using Endolysins in a Clinical Setting.在临床环境中使用内切溶素的优势和挑战。
Viruses. 2021 Apr 15;13(4):680. doi: 10.3390/v13040680.
9
Application of bacteriophage-derived endolysins to combat streptococcal disease: current state and perspectives.噬菌体来源的溶菌素在抗链球菌病中的应用:现状与展望。
Curr Opin Biotechnol. 2021 Apr;68:213-220. doi: 10.1016/j.copbio.2021.01.012. Epub 2021 Jan 30.
10
Phage-Encoded Endolysins.噬菌体编码的内溶素
Antibiotics (Basel). 2021 Jan 28;10(2):124. doi: 10.3390/antibiotics10020124.